ncDRMarker: a computational method for identifying non-coding RNA signatures of drug resistance based on heterogeneous network

  • Yang H
  • Xu Y
  • Shang D
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

… hsa-miR-30c-5p, 31447008 … is a chemotherapeutic agent that has been widely used in the treatment of lung, ovarian, and breast cancer, and miR-92a … of erlotinib), and studies showed that miR-124-3p mediates erlotinib resistance in K-RAS mutated pancreatic cancer by targeting …

Cite

CITATION STYLE

APA

Yang, H., Xu, Y., Shang, D., Shi, H., Zhang, C., Dong, Q., … Li, X. (2020). ncDRMarker: a computational method for identifying non-coding RNA signatures of drug resistance based on heterogeneous network. Annals of Translational Medicine, 8(21), 1395–1395. https://doi.org/10.21037/atm-20-603

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free